AI Tests 120+ Cancer Drugs to Find Perfect Match for Patients

Imagine getting cancer treatment that doctors know will work for you specifically, not just what worked for other patients on average. That future is arriving now, thanks to artificial intelligence that's revolutionizing how we fight cancer.

UK company PreComb has developed technology that grows miniature living replicas of a patient's actual tumor in the lab. Scientists can then test dozens or even hundreds of different drugs on these "tumor avatars" to see exactly which treatments will defeat that specific cancer.

Right now, more than 100,000 people in the UK receive chemotherapy each year without doctors knowing in advance if those drugs will actually work. Many patients suffer devastating side effects from treatments that ultimately fail to stop their cancer.

The problem is that cancer isn't one disease. Even tumors that look identical can behave completely differently based on their unique mutations and biology.

Professor Javad Nazarian at the University of Zurich is using the platform for children with aggressive brain cancers. His team can test over 120 drugs matched to each patient's tumor biology within two to three weeks.

The AI monitors thousands of images of the miniature tumors to track whether cancer cells are growing, stabilizing, or dying off. This gives doctors a clear picture of what will happen before the patient takes a single pill.

"These are very deadly tumors, and in many cases, they are still incurable," Professor Nazarian explained. "Until now we have not had a reliable way of seeing and measuring how a patient's cancer is responding to drugs."

For brain tumor patients, this speed matters enormously. Clinicians often have just a narrow window after surgery to decide on treatment, sometimes only a few weeks.

PreComb is currently working on small-cell lung cancer, bowel cancer, bone cancer, and both adult and pediatric brain cancers. Around 412,000 people are diagnosed with cancer in the UK each year, one person every 75 seconds.

Why This Inspires

This breakthrough represents a fundamental shift from treating cancer based on statistics to treating each person's unique disease. Instead of hoping chemotherapy works while patients endure toxic side effects, doctors will have evidence before treatment begins.

The technology could buy precious time or even save lives for patients with deadly tumors who can't afford trial and error. It transforms cancer care from educated guessing into precision medicine.

For families watching loved ones struggle through ineffective treatments, this offers something powerful: hope backed by science, not just chance.

The future of cancer treatment isn't one-size-fits-all anymore.